2026 NIDA $100,000 Start an SUD Startup Challenge: Six-Month Mentorship and Startup Prizes

2026 NIDA $100,000 Start an SUD Startup Challenge: Six-Month Mentorship and Startup Prizes

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is accepting applications for its 2026 “$100,000 Start an SUD Startup” Challenge. The competition is for teams with a research idea related to drug use, drug misuse, or substance use disorder (SUD) that could become the foundation of a new U.S.-based startup.

This is not a conventional research grant and it is not a general business-plan contest. NIDA is looking for early founders who can connect a real unmet need to a defensible research idea, a practical product, and a plausible customer. The strongest teams will receive a six-month biomedical product-development mentorship from NIDA entrepreneurship experts. Teams that complete the mentorship requirements and the later startup presentation may receive up to $10,000 each, with a total cash prize purse of up to $100,000.

The submission window opened on August 24, 2026, and closes on November 2, 2026, at 5:00 p.m. Eastern Time. NIDA expects to announce Stage 1 winners on January 5, 2027, and Stage 2 winners in July 2027. The dates are subject to change, so teams should verify the official announcement before submitting.

Key details

What the opportunity offers

The first stage is a non-cash prize: a six-month product-development mentorship led by NIDA entrepreneurship experts. NIDA expects to select up to 12 winning teams. The mentorship is designed to help teams test whether an idea can become a viable product and business, rather than simply refine a laboratory hypothesis.

The commitment is substantial. The published challenge description calls for five scheduled monthly lectures of 90 minutes, five monthly office-hour meetings of 60 to 90 minutes with an assigned mentor, and five monthly homework assignments due about 48 hours before the office-hour meeting. Each team member should plan for approximately 25 hours per month throughout the six-month program. A team that cannot protect that time should not treat the mentorship as a casual prize or an occasional advisory call.

Stage 2 is the cash component. Teams that complete the training process may be selected to deliver a startup presentation and receive up to $10,000 each. The total cash purse available across all winning teams is up to $100,000. NIDA says the cash can help a team develop a minimum viable product, gather customer feedback, test the feasibility of creating a science-based business, and develop concepts that may support a future NIDA Small Business Innovation Research or Small Business Technology Transfer application.

The prize is paid directly and in full to the Team Leader, who is responsible for distributing it among team members. NIH and NIDA do not manage that internal division. Cash prizes are paid by electronic funds transfer and may be subject to federal income-tax reporting and withholding. Winning teams should be prepared to provide bank-account and routing information if requested.

Who this challenge fits

The competition is a strong fit for a small, complementary founding team rather than a solo applicant. Every team must contain at least three and no more than five individuals, all of whom must be at least 18 years old when the submission is made. A team may be newly assembled, associated with an academic institution or nonprofit, or already part of an early-stage company.

The team must name a Team Leader. That person registers, submits the package, and must be a U.S. citizen or permanent resident to make the team eligible for a cash or non-cash prize. Non-U.S. citizens and non-permanent residents may participate as team members if the other requirements are met, but they cannot receive a monetary prize in whole or in part under the published rules. Teams should settle their internal roles and prize-distribution arrangements before submission.

The team must intend to form a U.S.-based startup or already be a new U.S.-based startup in an early stage of formation and growth. NIDA uses “product” broadly. A physical biomedical device, drug, research tool, software-as-a-service product, subscription, service, data product, or new delivery model can qualify if it creates value for a defined customer.

No prior startup experience is required. However, the team should show that it can work together under uncertainty, accept coaching, and carry an idea from evidence of need toward a product that somebody could use or buy. A team made up only of technical specialists may need to add a customer or clinical perspective. A business-only team may need a credible technical or research lead.

What ideas are in scope

The idea must relate directly to drug use, drug misuse, or SUD, or must be a technology that can be extended or adapted for those areas. NIDA is interested in ideas that can further understanding, prevention, treatment, measurement, delivery, or other practical responses connected to these topics.

The connection must be real. A general health platform with no clear SUD use case is a weak fit. For a platform technology, NIDA says the idea should be broad enough to address multiple conditions or indications, including SUD. An idea that works only for cancer or diabetes, with no credible SUD application, is not appropriate for this challenge.

NIDA’s definition allows more than a new medicine. A research tool that improves the study of neurobiology relevant to SUD may fit. So may a diagnostic or monitoring device, a clinical workflow product, a software tool for researchers or providers, or a service for an underserved customer group. Repurposing existing technology for a new SUD use is also possible, provided the proposed application is evidence-based and not merely a relabeling exercise.

Proposals focused only on alcohol use disorder or pain will not be accepted. Teams working across addiction, mental health, pain, or related fields should make the SUD or drug-use component explicit and central. The official rules also exclude certain participants, including federal entities, federal employees acting within the scope of their employment, HHS employees acting in their personal capacity, challenge judges, and people involved in designing or running the competition or their immediate families.

Active SBIR or STTR grantees and applicants whose SBIR or STTR applications are currently under review are not eligible to participate. Federal grant or cooperative-agreement funds cannot be used to develop the submission or support the team’s challenge work. Federal contractors also cannot use federal contract funds for those purposes.

How to apply

The team leader must register and send the complete Stage 1 Submission Package by email to the address specified in the official announcement. The current submission period ends November 2, 2026, at 5:00 p.m. Eastern Time. The official page is the controlling source for the registration form, submission email, and any updates to the schedule.

The package has three practical parts: the registration form, a five-minute team video, and a written proposal in PDF format. The video must be uploaded to YouTube as “unlisted,” with the link included in the submission. It is intended to introduce the team, not to replace the written explanation of the idea.

The written proposal may be no more than four pages, must use at least one-inch margins, must use a font no smaller than 11-point Arial, and must be written in English. The announcement divides the proposal into four components: one page for need validation, one page for the idea, one and a half pages for the prototype and envisioned user journey, and half a page for team technical competence and research experience. Submissions that do not follow the required format may be disqualified.

What to put in the team video

NIDA gives the team video a specific purpose: demonstrate the people behind the idea and their ability to commit to the mentorship. The announcement uses three informal role labels. The “hacker” is the technical lead who understands how the product could be developed. The “hipster” is the end-user or customer-need lead who understands clinical practice, healthcare delivery, and user experience. The “hustler” is the business or entrepreneurial lead who can focus on customer discovery, business objectives, and the emerging business plan.

The labels are less important than the underlying coverage. In five minutes, show who performs each function, how long the members have known one another, and what distinctive experience brought them to the idea. Explain why each person wants to become a founder and how each member will manage the roughly 25-hour monthly workload. The video should make the team’s working relationship believable. Listing impressive credentials without showing ownership, availability, or cooperation leaves the highest-weighted judging area underdeveloped.

Keep the recording accessible through the unlisted link and test the link from a private browser before sending it. Do not use NIH, NIDA, or HHS logos, official seals, or language suggesting federal endorsement in the submission materials.

How to build the written proposal

Start with the need, not the invention. The need-validation section should explain how, when, where, and with whom the team established that a meaningful problem exists. NIDA specifically asks teams to address whether the target customer would be willing to pay. Include the customer group, the current alternative or standard of care, evidence from interviews or other research, a basic market-size calculation, and a competitor analysis where relevant.

The idea section should explain the scientific or technical basis for the proposed product and how it addresses the validated need. It should be defensible and evidence-based. Cite the research that matters, but use the limited space for evidence that changes the reader’s confidence in the idea. A long literature review is less useful than a concise chain from observation to mechanism to proposed use.

The prototype section should make the product tangible. Describe what the first credible version would contain, how a user would encounter it, what the user would do step by step, and what output or benefit would result. Use simple terms. Distinguish what has already been built from what is only envisioned. If the product depends on a clinician, lab, researcher, patient, payer, or other participant, show where that person fits in the workflow.

The final section should connect the team’s technical competence and research experience to the work ahead. Include only relevant experience. The team does not need to use an NIH Bibliographic Sketch format. It does need to show that someone can develop the core technology, someone understands the customer and use setting, and someone can move the work toward a U.S.-based startup.

What the judges will look for

Stage 1 judging uses four published criteria. Team and founder aptitude is worth up to 20 points. The judges look for ability, dedication, collaboration, persistence under business uncertainty, commitment to the six-month mentorship, and willingness to be coached. This is why the team video and the time-commitment explanation matter.

Validation of an unmet need is worth up to 10 points. Evidence that a problem exists is not the same as evidence that the proposed customer experiences it, will use the product, or will pay for it. Describe the method behind the evidence and its limitations.

Idea novelty is worth up to 5 points. Novelty can come from a new scientific concept, a new method, a new instrument, a new intervention, or a meaningful extension of an existing technology into SUD research. Do not claim novelty merely because the product has a new name.

Commercialization is worth up to 10 points. Identify end users and purchasers separately when they are different people. Explain the competitive position, regulatory path, and reimbursement path where those considerations apply. The judges also use the video conference after initial review to gather more detail about the submission and the team’s availability, interest, and commitment. A proposal that makes claims the team cannot explain live is risky.

Timeline and preparation plan

The published schedule lists August 17, 2026, as the challenge launch and August 24 at 9:00 a.m. Eastern Time as the submission start. The deadline is November 2 at 5:00 p.m. Eastern Time. Team interviews are scheduled for November 9 through November 30, followed by judging from December 1 through December 21. Stage 1 winners are expected on January 5, 2027. Stage 2 winners are expected in July 2027.

Use the time before submission to resolve the highest-risk unknowns. Confirm that the Team Leader meets the citizenship or permanent-residence rule. Check the SBIR and STTR exclusion. Identify the exact SUD application. Interview representative users and purchasers. Record what the current solution costs in time, money, delay, or clinical risk. Decide what the smallest credible prototype would demonstrate. Then build the four-page document around the evidence that answers those questions.

Leave time for team review. The registration form, video link, proposal page count, margins, font, file format, and email package all need to be checked together. A submission can contain a strong idea and still lose consideration if it is late, incomplete, unintelligible, or outside the required format.

Common mistakes to avoid

The most serious mistake is treating the competition as a generic startup pitch. NIDA wants a research idea tied to drug use, drug misuse, or SUD and a credible route to a product. Make that connection visible in the first paragraph and carry it through the customer, prototype, and commercialization sections.

Another mistake is describing a large market without identifying the first buyer. A market-size estimate should support a focused entry point, not substitute for one. Name the first user, the purchaser, the current alternative, and the reason the new product could be adopted.

Teams should also avoid hiding uncertainty. If regulatory classification, reimbursement, data access, or clinical validation is not yet known, say what is unknown and explain how the mentorship would help resolve it. Honest, testable next steps are more persuasive than unsupported certainty.

Finally, do not overlook the team’s operating agreement. NIDA pays any cash prize to the Team Leader, does not distribute money among members, and requires the entire team to participate in the mentorship. Discuss internal responsibilities, time availability, intellectual-property ownership, and prize distribution before submission.

Frequently asked questions

Can one person apply alone?

No. The published rules require a team of at least three and no more than five individual participants.

Do all team members have to be U.S. citizens?

No. The Team Leader must be a U.S. citizen or permanent resident for the team to be eligible for a prize. Non-U.S. citizens and non-permanent residents may participate as team members, but they are not eligible to receive a monetary prize in whole or in part.

Does the team need an incorporated company?

Not necessarily. Teams may be newly formed or associated with an institution, nonprofit, or early-stage company. They must intend to form a U.S.-based startup or already be a new U.S.-based startup.

Is this a grant that guarantees SBIR or STTR funding later?

No. NIDA says the challenge can help teams develop concepts for a future SBIR or STTR application and that staff will provide technical assistance about the grant process. Participation or winning does not guarantee a later grant award.

Can an idea focus on pain or alcohol use disorder?

No. The published rules say submissions pursuing ideas in alcohol use disorder and pain will not be accepted. A related platform may be appropriate only when its SUD or drug-use application is clear and substantive.

What happens after Stage 1?

Stage 1 winners complete the six-month mentorship. They then submit a five-page startup package and a five-slide presentation for a Peer Board Meeting. Further Stage 2 details are provided during the mentorship. Teams are evaluated on completion of the training, quality of the work, coach nomination, and the final presentation.

Official links and next steps

Read the official 2026 NIDA “$100,000 Start an SUD Startup” Challenge announcement before preparing the package. It contains the current registration materials, full eligibility rules, submission requirements, judging criteria, prize conditions, and contact information. The page was last reviewed on August 17, 2026, and the schedule is marked subject to change.

For a team that has a genuine SUD-related research idea but needs help turning it into a product and company, this challenge offers a useful combination: structured founder coaching, direct technical and business feedback, and a possible cash award after completion. The right first step is not to write a polished pitch. It is to form a three-to-five-person team, confirm eligibility, document the unmet need, and test whether the proposed product has a specific user, purchaser, and path toward a U.S.-based startup before the November 2 deadline.